Activity Description & Educational Objectives
In this three-part activity, an expert panel discusses the clinical challenges associated with the management of autoimmune neuromuscular disorders. Topics addressed in this activity include the clinical characteristics and immunopathogenesis of Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy, multifocal motor neuropathy, and myasthenia gravis. In addition, available and emerging therapeutic options for the management of patients with these diseases are discussed.
Upon completion of this activity, participants should be better able to:
- Explain the underlying pathophysiology responsible for the development of autoimmune neuromuscular diseases
- Describe the clinical characteristics and features of autoimmune neuromuscular diseases
- Apply available and emerging treatment strategies for the management of patients with autoimmune neuromuscular diseases
This activity has been designed to meet the educational needs of neurologists, neuromuscular specialists, and other clinicians involved in autoimmune neuromuscular diseases.
Requirements for Successful Completion
In order to receive credit, participants must view the activity and complete the post-test and evaluation form. There are no pre-requisites and there is no fee to participate in this activity or to receive CME credit. Statements of Credit are awarded upon successful completion of the post-test and evaluation form.
Release and Expiration Dates: June 05, 2012 - June 04, 2013
Time to Complete: 60 minutes
Faculty & Disclosure / Conflict of Interest Policy
In accordance with ACCME requirements, Penn State College of Medicine has a conflict of interest policy that requires faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced.
Course Director and Moderator
Richard A. Lewis, MD
Professor and Associate Chair of Neurology
Wayne State University of Medicine
Richard A. Lewis, MD, has a financial interest/relationship or affiliation in the form of:
Consultant for Bristol-Myers Squibb and CSL Behring.
Grant/Research Support from Baxter and CSL Behring.
Peter D. Donofrio, MD
Professor of Neurology
Vanderbilt University Medical Center
Peter D. Donofrio, MD, has a financial interest/relationship or affiliation in the form of:
Consultant for CaridianBCT, Inc.; CSL Behring; and DIME.
Kirk A. Tacka, PhD
PVI, PeerView Institute for Medical Education
Kirk A. Tacka, PhD, currently has no financial interests/relationships or affiliations in relation to this activity.
Other PVI staff who may potentially review content for this activity have disclosed no relevant financial relationships.
Penn State College of Medicine staff and faculty involved in the development and review of this activity have disclosed no relevant financial relationships.
Sponsorship, Credit & Support
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Penn State College of Medicine and PVI, PeerView Institute for Medical Education. Penn State College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The Penn State College of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Information about CME credit for this activity is available by contacting Penn State at 717-531-6483 or ContinuingEd@hmc.psu.edu. Reference course # G5103-12-T.
This CME activity is jointly sponsored by Penn State College of Medicine and PVI, PeerView Institute for Medical Education.
This activity is supported by an educational grant from
Disclosure of Unlabeled Use
The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.
No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports.
Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.